Becton Dickinson and ($BDX) podcast mentions

Per Ticker.id: 1 Becton Dickinson and ($BDX) mention across 1 podcast (30 days) — timestamped, verifiable quotes, updated 2026-09-15.

1. Well, a little early there, but I recognize that Intel filed an S-1 to finish off this Altiros sale. David, I think your comment is really important. Here's why. I had Mark Fisher, the CEO of of Thermo on not that long ago, by the way. I mean, I'm sorry, Mark Casper. I'll tell you what really bothered me, David. We were sitting there talking about how strong business is. And Mark Casper is really a titan in this. And no one was listening to him. No one. Not unlike when we had— we had Becton Dickinson on. No one was listening. And Cardinal Health. No one was listening. When I spoke to them. I see. What's changed, David, for make it so that everybody's saying the same thing that they said 3 months ago and now we're listening?

   Jim Cramer · Squawk on the Street · 9AM HOUR: Trump Dismisses AI Fears, 10-Year Yield Hits Fresh 2007 Highs, the Fed's 2-Day Meeting In Focus 9/15/26 · 2026-09-15

2. And by the way, thank you for recommending Becton Dickinson a couple of months ago. It's up 32% on me.

   Speaker D · Mad Money w/ Jim Cramer · Mad Money w/ Jim Cramer 8/27/26 · 2026-08-27

3. First, you have Becton Dickinson, or BDX. They are the absolute titan of the smart infusion space. They have superior global scale, massive free cash flow generation, and unlike Baxter, their management is aggressively executing billions of dollars in stock buybacks to reward their shareholders. They are a much healthier compounder right now.

   Speaker B · Explain It to Me Please · 2026Q1 Baxter International Inc (BAX) · 2026-06-23